Dapoxetine Impurity ZY10
|
達(dá)泊西汀雜質(zhì)ZY10
|
2415108-74-4
|
Ticagrelor Impurity 105
|
替格瑞洛雜質(zhì)105
|
|
Atomoxetine EP Impurity G DiHCl (Mixture of Diastereomers)
|
阿托莫西汀EP雜質(zhì)G二鹽酸鹽(非對映體混合物)
|
2706536-33-4
|
(1R)-Avibactam Impurity 61
|
(1R)-阿維巴坦雜質(zhì)61
|
2007919-52-8
|
(1R,2R)-2-(2,4-Difluorophenyl)cyclopropanamine
|
(1R,2R)-2-(2,4-二氟苯基)環(huán)丙胺
|
2350925-61-8
|
Ticagrelor Related Compound 100
|
替格瑞洛相關(guān)化合物100
|
|
Linagliptin Impurity 50 HCl
|
利納列汀雜質(zhì)50 HCl
|
2803370-12-7
|
Glycopyrronium Bromide EP Impurity I Bromide
|
格隆溴銨EP雜質(zhì)I溴化物(RR-異構(gòu)體)(格隆溴銨USP相關(guān)化合物I(RR-異構(gòu)體))
|
|
Linagliptin Impurity 118
|
利格列汀雜質(zhì)118
|
|
N-Nitroso Posaconazole Impurity 128
|
N-硝基波沙康唑雜質(zhì)128
|
|
N-Nitroso Linagliptin Impurity 103
|
N-硝基利納列汀雜質(zhì)103
|
|
N-Nitroso Ticagrelor Impurity 63
|
N-亞硝基替格瑞洛雜質(zhì) 63
|
|
N-Nitroso Ticagrelor Impurity 113
|
N-亞硝基替格瑞洛雜質(zhì) 113
|
|
Glycopyrronium Bromide EP Impurity L (Glycopyrrolate USP Related Compound L)
|
格隆溴銨EP雜質(zhì)L(格隆溴銨USP相關(guān)化合物L(fēng))
|
19833-96-6
|
Dapoxetine Impurity ZY7
|
達(dá)泊西汀雜質(zhì)ZY7
|
|
N-Nitroso rac-Atomoxetine
|
消旋N-亞硝基托莫西汀雜質(zhì)
|
|
Baricitinib Impurity ZY5
|
巴瑞替尼雜質(zhì)ZY5
|
|
Posaconazole Impurity 119 DiHCl
|
泊沙康唑雜質(zhì)119二鹽酸
|
|
Piperacillin Impurity 31 Sodium Salt
|
哌拉西林雜質(zhì)31鈉鹽
|
|
Glycopyrrolate Impurity ZY2
|
格隆溴銨雜質(zhì)ZY2
|
|
Linagliptin Impurity ZY5
|
利格列汀雜質(zhì)ZY5
|
|
Linagliptin Impurity 97 Trifluoroacetate (Mixture of Isomers)
|
利格列汀雜質(zhì)97三氟乙酸鹽(異構(gòu)體混合物)
|
|
Risperidone Impurity 7 HCl
|
利培酮雜質(zhì)7鹽酸
|
|
Ticagrelor Related Compound 38 Tartrate
|
替格瑞洛雜質(zhì)1(替格瑞洛相關(guān)化合物38酒石酸鹽)
|
|
(1S,2R)-2-(3,5-Difluorophenyl)cyclopropanamine
|
(1S,2R)-2-(3,5-二氟苯基)環(huán)丙胺
|
|
(1R,2R)-2-(3,5-Difluorophenyl)cyclopropanamine
|
(1R,2R)-2-(3,5-二氟苯基)環(huán)丙胺
|
|
Posaconazole Impurity 49
|
泊沙康唑雜質(zhì)49
|
161532-65-6
|
Posaconazole Impurity 82
|
泊沙康唑雜質(zhì)82
|
|
Posaconazole Impurity 5
|
泊沙康唑雜質(zhì)5
|
|
Ticagrelor Related Compound 4 (6-Aminotetrahydro-2,2-Dimethyl-4H-Cyclopenta-1.3-dioxol-4-ol)
|
替格瑞洛相關(guān)化合物4(6-氨基四氫-2,2-二甲基-4H-環(huán)戊烷-1,3-二氧雜環(huán)戊醇-4-醇)
|
1446475-48-4
|
Ticagrelor Impurity 59
|
替格瑞洛雜質(zhì) 59
|
|
Tedizolid Impurity 20 Ditetrabutylammonium Salt
|
特地唑胺雜質(zhì)20二四丁基銨鹽
|
1239662-48-6
|
Chlorhexidine EP Impurity N
|
氯己定EP雜質(zhì)N
|
152504-10-4
|
Piperacillin Impurity 4
|
哌拉西林雜質(zhì)4
|
|
Glycopyrrolate Impurity 13
|
格隆溴銨雜質(zhì)13
|
126497-27-6
|
Linagliptin Impurity 106
|
利格列汀雜質(zhì)106
|
1955514-80-3
|
Posaconazole Impurity 29
|
泊沙康唑雜質(zhì)29
|
|
Posaconazole Piperazine N,N-Dioxide
|
泊沙康唑哌嗪N,N-二氧化物
|
1902957-95-2
|
cis-Risperidone N-Oxide
|
順式利培酮N-氧化物
|
1894509-66-0
|
Tedizolid Impurity 29
|
特地唑胺雜質(zhì)29
|
|
Tedizolid Impurity 40
|
特地唑胺雜質(zhì)40
|
|
Linagliptin Dimer Impurity 6
|
利格列汀二聚體雜質(zhì)6
|
1643364-41-3
|
Ticagrelor Related Compound 10
|
替格瑞洛相關(guān)化合物10
|
|
Ticagrelor Impurity 51
|
替格瑞洛雜質(zhì) 51
|
|
Ticagrelor Impurity 56
|
替格瑞洛雜質(zhì)56
|
|
Ticagrelor Impurity 74
|
替格瑞洛雜質(zhì)74
|
|
Ticagrelor Impurity 79
|
替格瑞洛雜質(zhì)79
|
|
Ticagrelor Impurity 97
|
替格瑞洛雜質(zhì)97
|
|
Linagliptin Impurity 37
|
利格列汀雜質(zhì)37
|
|
Dapoxetine Impurity 30
|
達(dá)泊西汀雜質(zhì)30
|
|
Tedizolid Impurity 76
|
特地唑胺雜質(zhì)76
|
2095840-86-9
|
Tedizolid Impurity 82
|
特地唑胺雜質(zhì)82
|
|
Linagliptin Impurity 53
|
利格列汀雜質(zhì)53
|
|
Posaconazole Impurity 84
|
泊沙康唑雜質(zhì)84
|
|
Ticagrelor Impurity 104
|
替格瑞洛雜質(zhì)104
|
|
Ticagrelor Impurity 12
|
替格瑞洛雜質(zhì)12
|
|
Ticagrelor Related Compound 90 HCl
|
替格瑞洛相關(guān)化合物 90鹽酸鹽
|
2227766-79-0
|
Atomoxetine Impurity 4 HCl
|
阿托莫西汀雜質(zhì)4鹽酸鹽
|
|
Lidocaine Impurity 13
|
利多卡因雜質(zhì)13
|
113225-33-5
|
Linagliptin Impurity 12
|
利格列汀雜質(zhì)12
|
2416949-69-2
|
Dapoxetine Impurity 19 HCl
|
達(dá)泊西汀雜質(zhì)19鹽酸鹽
|
2095189-99-2
|
Posaconazole-D-Glucuronide
|
泊沙康唑-D-葡萄糖醛酸
|
|
Posaconazole Impurity 14 (POS-I)
|
泊沙康唑雜質(zhì)14(POS-A)
|
|
Tedizolid Impurity 48
|
特地唑胺雜質(zhì)48
|
|
Dapoxetine Impurity 23
|
達(dá)泊西汀雜質(zhì)23
|
2249892-48-4
|
Dextromethorphan Impurity 7
|
右美沙芬雜質(zhì)7
|
367520-36-3
|
Linagliptin Impurity 92
|
利格列汀雜質(zhì)92
|
2428491-17-0
|
Posaconazole Impurity 76 oxalate
|
泊沙康唑雜質(zhì)76草酸鹽
|
1356330-68-1
|
Glycopyrrolate Impurity 25 Bromide
|
格隆溴銨雜質(zhì)25溴化物
|
1318114-75-8
|
Ticagrelor Impurity 37
|
替格瑞洛雜質(zhì)37
|
1395048-17-5
|
Linagliptin Impurity 45
|
利格列汀雜質(zhì)45
|
93703-24-3
|
Posaconazole Impurity ZY2
|
泊沙康唑雜質(zhì)ZY2
|
75051-59-1
|
N-Nitroso Risperidone EP Impurity M
|
N-亞硝基利培酮EP雜質(zhì)M
|
2416230-38-9
|
Atomoxetine Impurity 19
|
托莫西汀雜質(zhì)19
|
18776-12-0
|
Piperacillin Impurity 17
|
哌拉西林雜質(zhì)17
|
|
Tedizolid Impurity 67
|
特地唑胺雜質(zhì)67
|
380380-64-3
|
Risperidone Impurity 14
|
利培酮雜質(zhì)14
|
|
Piperacillin EP Impurity K
|
哌拉西林EP雜質(zhì)K
|
|
Linagliptin Impurity 63
|
利格列汀雜質(zhì)63
|
|
Azithromycin Impurity 31
|
阿奇霉素雜質(zhì)31
|
|
4-Hydroxy Atomoxetine (S-Isomer) Oxalate
|
4-羥基托莫西?。⊿-異構(gòu)體)草酸鹽
|
1797024-36-2
|
N-Nitroso Dextromethorphan EP Impurity A
|
N -亞硝基右美沙芬EP雜質(zhì)A
|
|
N-Nitroso Lidocaine EP Impurity D
|
N-硝基利多卡因EP雜質(zhì)D
|
|
Posaconazole Impurity 118
|
泊沙康唑雜質(zhì)118
|
|
Risperidone Impurity 23
|
利培酮雜質(zhì)23
|
|
Risperidone Impurity 31 (7-Fluoro Risperidone)
|
利培酮雜質(zhì)31(7-氟利培酮)
|
|
N-Nitroso Linagliptin Impurity 43
|
N-硝基利納列汀雜質(zhì)43
|
|
N-Nitroso Ticagrelor Impurity 41
|
N-亞硝基替卡瑞洛雜質(zhì)41
|
|
Tedizolid Impurity 18
|
特地唑胺雜質(zhì)18
|
|
Dapoxetine Impurity J HCl
|
達(dá)泊西汀雜質(zhì)J鹽酸鹽
|
|
rac-Dapoxetine N-Oxide
|
達(dá)泊西汀氮氧雜質(zhì)
|
|
Tedizolid Impurity 81
|
特地唑胺雜質(zhì)81
|
|
Bilastine Impurity ZY5
|
比拉斯汀雜質(zhì)ZY5
|
|
Posaconazole Impurity 28 Isomer
|
泊沙康唑雜質(zhì)28異構(gòu)體
|
|
Piperacillin Impurity 28 Sodium Salt
|
哌拉西林雜質(zhì)28鈉鹽
|
|
Glycopyrrolate Erythro Isomer (RS-Isomer)
|
格隆溴銨赤式異構(gòu)體(RS-異構(gòu)體)
|
|
Linagliptin Impurity ZY2
|
利格列汀雜質(zhì)ZY2
|
|
Linagliptin Impurity 55 (Mixture of Z and E Isomers)
|
利格列汀雜質(zhì)55(Z和E異構(gòu)體的混合物)
|
|
Linagliptin Impurity 85
|
利格列汀雜質(zhì)85
|
|
Ticagrelor Impurity 8 (Mixture of Diastereomers)
|
替格瑞洛雜質(zhì) 8(非對映體混合物)
|
|